Confinning microarray data - is it really necessary?

被引:64
作者
Rockett, JC
Hellmann, GM
机构
[1] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Reprod Toxicol Div, Res Triangle Pk, NC 27711 USA
[2] Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
关键词
D O I
10.1016/j.ygeno.2003.09.017
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The generation of corroborative data has become a commonly used approach for ensuring the veracity of microarray data. Indeed, the need to conduct corroborative studies has now become official editorial policy for at least 2 journals, and several more are considering introducing such a policy. The issue of corroborating microarray data is a challenging one-there are good arguments for and against conducting such experiments. However, we believe that the introduction of a fixed requirement to corroborate microarray data, especially if adopted by more journals, is overly burdensome and may, in at least several applications of microarray technology, be inappropriate. We also believe that, in cases in which corroborative studies are deemed essential, a lack of clear guidance leaves researchers unclear as to what constitutes an acceptable corroborative study. Guidelines have already been outlined regarding the details of conducting microarray experiments. We propose that all stakeholders, including journal editorial boards, reviewers, and researchers, should undertake concerted and inclusive efforts to address properly and clarify the specific issue of corroborative data. In this article we highlight some of the thorny and vague areas for discussion surrounding this issue. We also report the results of a poll in which 76 life science journals were asked about their current or intended policies on the inclusion of corroborative studies in papers containing microarray data. Published by Elsevier Inc.
引用
收藏
页码:541 / 549
页数:9
相关论文
共 38 条
  • [1] A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells
    Aoyagi, K
    Tatsuta, T
    Nishigaki, M
    Akimoto, S
    Tanabe, C
    Omoto, Y
    Hayashi, S
    Sakamoto, H
    Sakamoto, M
    Yoshida, T
    Terada, M
    Sasaki, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (04) : 915 - 920
  • [2] Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression
    Barrett, JC
    Kawasaki, ES
    [J]. DRUG DISCOVERY TODAY, 2003, 8 (03) : 134 - 141
  • [3] Alternative and aberrant splicing of MDM2 mRNA in human cancer
    Bartel, F
    Taubert, H
    Harris, LC
    [J]. CANCER CELL, 2002, 2 (01) : 9 - 15
  • [4] One-stop shop for microarray data - Is a universal, public DNA-microarray database a realistic goal?
    Brazma, A
    Robinson, A
    Cameron, G
    Ashburner, M
    [J]. NATURE, 2000, 403 (6771) : 699 - 700
  • [5] Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells
    Burczynski, ME
    McMillian, M
    Ciervo, J
    Li, L
    Parker, JB
    Dunn, RT
    Hicken, S
    Farr, S
    Johnson, MD
    [J]. TOXICOLOGICAL SCIENCES, 2000, 58 (02) : 399 - 415
  • [6] Carlisle AJ, 2000, MOL CARCINOGEN, V28, P12, DOI 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO
  • [7] 2-Q
  • [8] Post-analysis follow-up and validation of microarray experiments
    Chuaqui, RF
    Bonner, RF
    Best, CJM
    Gillespie, JW
    Flaig, MJ
    Hewitt, SM
    Phillips, JL
    Krizman, DB
    Tangrea, MA
    Ahram, M
    Linehan, WM
    Knezevic, V
    Emmert-Buck, MR
    [J]. NATURE GENETICS, 2002, 32 (Suppl 4) : 509 - 514
  • [9] Environmental Protection Agency (EPA), 2002, INT GEN POL
  • [10] DNA microarrays: Boundless technology or bound by technology? Guidelines for studies using microarray technology
    Firestein, GS
    Pisetsky, DS
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (04): : 859 - 861